H

ello, everyone, and how are you today? We are doing just fine, thank you, despite a busy schedule caused by a road trip to the Woodstock-like gathering of biotech types. As you might imagine, this requires finding cups of stimulation at regular intervals. Perhaps you can relate. After all, this is an exceedingly busy few days, yes? Well, wherever you are or whatever you may be doing, feel free to join us. Firing up the neurons can be helpful. On that note, here are some tidbits to help you along. Hope your day goes well and do drop us a line if something interesting pops up …

A group of shareholders, including several founding family members of Takeda Pharmaceutical (TKPYY), are trying to derail the $62 billion acquisition of Shire (SHPG), blasting the deal as “the height of madness,” The Financial Times reports. The dissidents, who hired a former UBS analyst to back their campaign, hold 1 percent of Takeda stock, giving them little real power to overturn the takeover. But their offensive has drawn outsized attention in a country where founding family voices hold emotional sway over votes of mom-and-pop investors, who account for a quarter of Takeda shareholders.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy